MK

Miriam Kidron

Chief Scientific Officer & Director

Oramed Pharmaceuticals

Oramed Pharmaceuticals Pipeline

DrugIndicationPhase
ORMD-0801Type 2 DiabetesPhase 3
ORMD-0901Undisclosed Metabolic IndicationPhase 1